GLIPR1 and pachyonychia congenita: However, the low penetrance (~17%) and late onset (no mortality until at least 15 months of age) of tumours in these mice suggests that the cohort size and length of monitoring of the Glipr1-/- mice in this study may have been insufficient to observe potentially enhanced PC tumorigenesis.